Contract for the supply of DTaP/IPV/Hib
key details
| Status | complete |
|---|---|
| Category (CPV) | 33651000 |
| Region | Scotland, Wales, Northern Ireland |
| Deadline | 1 Apr 2016 |
| Contract start | 1 Apr 2017 |
| Contract end | 31 Mar 2019 |
| Procedure | open |
| SME suitable | No |
| OCID | ocds-b5fd17-5c93c404-adc9-11e6-9901-0019b9f3037b |
Award
| Supplier | Value | Date | Status |
|---|---|---|---|
| GlaxoSmithKline UK Ltd | £0 | 15 Aug 2016 | active |
description
The provision of diphtheria, tetanus, acellular pertussis, inactivated polio vaccine, Haemophilus influenzae type b vaccine (DTaP/IPV/Hib) to be used as part of the national childhood immunisation programme, deliveries will be required from 1 April 2017 to 31 March 2019, with an option to extend for up to an additional 24 months
notice history
2 notices published against this procurement.
| Published | Type | Regime | Notice |
|---|---|---|---|
| 12 Feb 2015 | Planning (planning) | · | ocds-b5fd17-38a24eb7-adc8-11e6-9901-0019b9f3037b-60701-cm-phv-12-5356 |
| 22 Dec 2016 | Award update (awardUpdate) | · | a3e6eb5f-9250-48fa-959a-2ee3f164ea0e-122396 |
more from COMMERCIAL MEDICINES UNIT
- NHS Framework Agreement for Branded Pharmaceuticals - North of England Tranche A. · £575,675,600 · 24 Apr 2017
- NHS Framework Agreement for the Midlands and East Pharmacy Purchasing Group for the supply of Proprietary Pharmaceuticals - Tranche B · £102,379,487 · 24 Apr 2017
- Contract for the supply of BCG vaccine · 9 Jan 2017
- Contract for the supply of human papillomavrius vaccine · 22 Dec 2016
- NHS National Pharmaceuticals - Wave 10c Offer reference number: CM/PHG/15/5466 Period of framework agreement: Dates detailed below with options to extend up to a maximum period of 40 months. Potential periods of call-offs under the framework agreement: Oral Products: All Regions 01/07/2017 to 28/02/2019 (20 months) Hospital Only Products: Central and South West (CESW) 01/07/2017 to 30/06/2018 (12 months); North West and Eastern and North London (NWLN) 01/07/2017 to 30/06/2018 (12 months) and South East and South London and North East and Yorkshire (LSNE) 01/07/2017 to 30/06/2018 (12 months) · £182,500,000 · 16 Dec 2016
- NHS Framework Agreement for Hepatitis C Medicines for Midlands and East and North of England regions · £85,000,000 · 25 Nov 2016
- Invitation to offer for NHS Framework Agreement for Branded Pharmaceuticals for London – Tranche A (inc. Hepatitis C) · £201,544,684 · 18 Nov 2016
- Contract for the supply of BCG vaccine · 18 Nov 2016
all contracts from this buyer →
similar contracts awarded
Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.
- Contract for the supply of Meales, Mumps and Rubella (MMR) vaccine · DEPARTMENT OF HEALTH
- Contract for supply combined atropine & pralidoxime chloride auto-injector · Department of Health
- Contract for the supply of Botulism Antitoxin Heptavalent ((A,B,C,D,E,F,G) - (Equine)) · Department of Health
- Inactivated flu vaccine 2018 season · DEPARTMENT OF HEALTH
- Contract for the supply of human papillomavrius vaccine · COMMERCIAL MEDICINES UNIT
- Contract for the supply of BCG vaccine · COMMERCIAL MEDICINES UNIT
- Contract for the supply of Measles, Mumps and Rubella vaccine (MMR) · DEPARTMENT OF HEALTH
- Contract for the supply if diphtheria, tetanus, pertussis and poliomyelitis vaccine · DEPARTMENT OF HEALTH
source
Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.